North Carolina Hepatitis B Research Network
North Carolina Hepatitis B Research Network
批准号:
9352985
负责人:
MICHAEL W FRIED
金额:
$6.36万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-30 至 2020-05-31
关键词:
Academic Medical CentersAdultAgeAncillary StudyAnti-Inflammatory AgentsAnti-inflammatoryCharacteristicsChildhoodChronic Hepatitis BCirrhosisClinicalClinical DataClinical TrialsCohort StudiesCombined Modality TherapyComorbidityConduct Clinical TrialsControl GroupsDataDevelopmentDiseaseEicosanoidsEnrollmentEpidemiologic StudiesEtiologyExposure toFamilyFlareFosteringGenderGeographic LocationsGoalsHealthHepatitis BHepatitis B Surface AntigensHepatitis B VirusHepatitis B e AntigensHepatitis EImmuneImmune ToleranceImmune responseImmunoglobulin GImmunoglobulin MInfectionInflammationLeadershipLinkLipid PeroxidationLipidsLiverLiver FailureLiver diseasesMeasuresMethodsMolecular ProfilingNatural HistoryNorth AmericaNorth CarolinaParticipantPathogenesisPatientsPhasePilot ProjectsPlayPopulationPrevalencePrimary carcinoma of the liver cellsPublicationsPublishingRNARaceRegulationResearchResearch PersonnelRoleSamplingSerologicalSerumTestingTransaminasesUnited StatesUniversitiesViralViremiaWritingco-infectioncohortexperiencefollow-upglobal healthinnovationlipid mediatorliver injurymembernovelpathogenresearch studyresponseseroconversionsuccesstranslational studytrial comparing
中文摘要
描述(由申请人提供):乙肝研究网络(HBRN)成立于2008年,是一个研究乙肝疾病新方面的临床和翻译研究人员联盟。HBRN的重点是进一步阐明美国慢性乙肝的自然历史,并在免疫活跃(IA)和免疫耐受(IT)人群中进行临床试验,比较单一疗法和联合疗法。利用成人队列研究的基线数据进行了许多流行病学研究,几项研究已经出版或提交出版。同样,辅助研究将进一步加深我们对乙肝发病机制的理解,利用
与生物检疫有关的强有力的临床数据已经启动。这份续签申请将侧重于继续HBRN的非凡努力,详细说明北卡罗来纳州乙肝研究联盟在这一努力中的不可或缺的作用,并提出有助于了解乙肝发病机制的新颖翻译研究。
英文摘要
DESCRIPTION (provided by applicant): The Hepatitis B Research Network (HBRN) was established in 2008 as a consortium of clinical and translational investigators studying novel aspects of hepatitis B disease. The focus of the HBRN has been to further elucidate the natural history of chronic hepatitis B in the United States and to conduct clinical trials comparing monotherapy versus combination therapy in immuneactive (IA) and immunetolerant (IT) populations. Numerous epidemiological studies utilizing the baseline data from the Adult Cohort Study have been implemented and several have been published or submitted for publication. Similarly, ancillary studies that will further our understanding of HBV pathogenesis, utilizing the
robust clinical data linked with biospecimens, have been initiated. This renewal application will focus on continuing the extraordinary efforts of the HBRN, detail the integral role of The North Carolina Hepatitis B Research Consortium in this endeavor, and propose novel translational studies that will contribute to understanding HBV pathogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The North Carolina Hepatitis Beta Clinical Research Network
-
批准号:7932806
-
项目类别:
-
资助金额:$32.05万
-
财政年份:2008
-
负责人:MICHAEL W FRIED
-
依托单位:
The North Carolina Hepatitis Beta Clinical Research Network
-
批准号:8545812
-
项目类别:
-
资助金额:$34.96万
-
财政年份:2008
-
负责人:MICHAEL W FRIED
-
依托单位:
The North Carolina Hepatitis Beta Clinical Research Network
-
批准号:7578384
-
项目类别:
-
资助金额:$14.91万
-
财政年份:2008
-
负责人:MICHAEL W FRIED
-
依托单位:
The North Carolina Hepatitis Beta Clinical Research Network
-
批准号:8330280
-
项目类别:
-
资助金额:$37.2万
-
财政年份:2008
-
负责人:MICHAEL W FRIED
-
依托单位:
The North Carolina Hepatitis Beta Clinical Research Network
-
批准号:8139899
-
项目类别:
-
资助金额:$22.02万
-
财政年份:2008
-
负责人:MICHAEL W FRIED
-
依托单位:
DIVISION OF DIGESTIVE DISEASES SERUM AND TISSUE BANK
-
批准号:7716753
-
项目类别:
-
资助金额:$0.02万
-
财政年份:2008
-
负责人:MICHAEL W FRIED
-
依托单位:
The North Carolina Hepatitis Beta Clinical Research Network
-
批准号:8728819
-
项目类别:
-
资助金额:$14.41万
-
财政年份:2008
-
负责人:MICHAEL W FRIED
-
依托单位:
The North Carolina Hepatitis Beta Clinical Research Network
-
批准号:7693739
-
项目类别:
-
资助金额:$41.59万
-
财政年份:2008
-
负责人:MICHAEL W FRIED
-
依托单位:
A phase I/II randomized, placebo controlled trial of silymarin for hepatitis C
-
批准号:7123141
-
项目类别:
-
资助金额:$14.94万
-
财政年份:2006
-
负责人:MICHAEL W FRIED
-
依托单位:
A phase I/II randomized, placebo controlled trial of silymarin for hepatitis C
-
批准号:7497799
-
项目类别:
-
资助金额:$4.25万
-
财政年份:2006
-
负责人:MICHAEL W FRIED
-
依托单位:
A phase I/II randomized, placebo controlled trial of silymarin for hepatitis C
-
批准号:7275247
-
项目类别:
-
资助金额:$28.72万
-
财政年份:2006
-
负责人:MICHAEL W FRIED
-
依托单位:
A phase I/II randomized, placebo controlled trial of silymarin for hepatitis C
-
批准号:7480368
-
项目类别:
-
资助金额:$34.46万
-
财政年份:2006
-
负责人:MICHAEL W FRIED
-
依托单位:
PEGASYS PLUS AMANTADINE AND PEGASYS PLUS AMANTADINE PLUS RIBAVIRIN
-
批准号:7377403
-
项目类别:
-
资助金额:$0.02万
-
财政年份:2005
-
负责人:MICHAEL W FRIED
-
依托单位:
VIRAHEP-C: A STUDY OF ANTIVIRAL RESISTANCE IN AFR AMER/CAUCASIAN-HEP C
-
批准号:7377429
-
项目类别:
-
资助金额:$1.34万
-
财政年份:2005
-
负责人:MICHAEL W FRIED
-
依托单位:
Mentoring Junior Faculty: Hepatitis C Clinical Research
-
批准号:6712400
-
项目类别:
-
资助金额:$13.93万
-
财政年份:2004
-
负责人:MICHAEL W FRIED
-
依托单位:
Mentoring Junior Faculty: Hepatitis C Clinical Research
-
批准号:7452374
-
项目类别:
-
资助金额:$13.93万
-
财政年份:2004
-
负责人:MICHAEL W FRIED
-
依托单位:
INTERFERON RESISTANCE IN AFRICAN-AMERICANS
-
批准号:7200198
-
项目类别:
-
资助金额:$0.09万
-
财政年份:2004
-
负责人:MICHAEL W FRIED
-
依托单位:
Mentoring Junior Faculty: Hepatitis C Clinical Research
-
批准号:6881617
-
项目类别:
-
资助金额:$13.93万
-
财政年份:2004
-
负责人:MICHAEL W FRIED
-
依托单位:
Mentoring Junior Faculty: Viral hepatitis Clinical Research
-
批准号:8663882
-
项目类别:
-
资助金额:$15.33万
-
财政年份:2004
-
负责人:MICHAEL W FRIED
-
依托单位:
Mentoring Junior Faculty: Viral hepatitis Clinical Research
-
批准号:8068356
-
项目类别:
-
资助金额:$16.26万
-
财政年份:2004
-
负责人:MICHAEL W FRIED
-
依托单位:
海外基金